See All Slides - tctmd.com

Slides

Presentation TCT 2017

Debate: Should CHIP Success Be Defined by Complete Revascularization? Pro!

Presenter: Farouc Jaffer, Ajay J. Kirtane, William L. Lombardi

October 31, 2017

Presentation TCT 2017

Coronary Flow, Collateral Flow, and Fractional Flow Reserve in Culprit and Nonculprit Lesions in STEMI

Presenter: David P. Faxon, Robert S. Schwartz, Matthias Götberg

October 31, 2017

Presentation TCT 2017

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

Presenter: Azeem Latib, Manel Sabate

October 31, 2017

Presentation TCT 2017

Case #3: Recanalization of a CTO

Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Alexandre Schaan Quadros

October 31, 2017

Presentation TCT 2017

Ukraine Comments to Colombia: How I Would Manage This Case

Presenter: Mohammad Al-Mutairi, Ahmed Magdy, Liliya Sorokhtey

October 31, 2017

Presentation TCT 2017

Cath Lab Economics 101: MACRA and MIPS

Presenter: Peter L Duffy, Hadley Wilson, Daniel M. Kolansky

October 31, 2017

Presentation TCT 2017

Industry Perspective on Real-World Evidence for TAVR Outcomes Where are the Opportunities?

Presenter: Martin B. Leon, Changfu Wu, Larry L. Wood

October 31, 2017

Presentation TCT 2017

Keynote Address: Grand Summary of the Vast TMVR Landscape - Differentiating Features and Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Bernard Prendergast

October 31, 2017

Presentation TCT 2017

SAPIEN 3 TAVR Technology Review (Including Sapien 3 ULTRA) and Clinical Program Updates

Presenter: John G. Webb

October 31, 2017

EXCEL: Core Findings Revisited and New Data

Presentation TCT 2017

EXCEL Trial 3-Year Results Updated and New Data

Presenter: Antonio Colombo, David E. Kandzari, Gregg W. Stone

October 31, 2017

Advertisement

Slides

Debate: Should CHIP Success Be Defined by Complete Revascularization? Pro!

Coronary Flow, Collateral Flow, and Fractional Flow Reserve in Culprit and Nonculprit Lesions in STEMI

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

Case #3: Recanalization of a CTO

Ukraine Comments to Colombia: How I Would Manage This Case

Cath Lab Economics 101: MACRA and MIPS

Industry Perspective on Real-World Evidence for TAVR Outcomes Where are the Opportunities?

Keynote Address: Grand Summary of the Vast TMVR Landscape - Differentiating Features and Outcomes

SAPIEN 3 TAVR Technology Review (Including Sapien 3 ULTRA) and Clinical Program Updates

EXCEL Trial 3-Year Results Updated and New Data

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content